Ainos (OTCMKTS:AIMD) Trading 8.6% Higher – Here’s What Happened

Ainos, Inc. (OTCMKTS:AIMD) traded up 8.6% on Thursday . The company traded as high as $0.77 and last traded at $0.73. 366,739 shares changed hands during mid-day trading, a decline of 69% from the average session volume of 1,190,598 shares. The stock had previously closed at $0.67.

Ainos Trading Up 8.6 %

The stock has a market cap of $10.28 million, a PE ratio of -0.84 and a beta of 1.45. The company has a current ratio of 1.92, a quick ratio of 1.45 and a debt-to-equity ratio of 0.08. The firm has a fifty day simple moving average of $0.58 and a two-hundred day simple moving average of $0.55.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.